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Resumo 
A solubilidade de N-acetyl-L-cysteine (NAC), Coumarin (COU) e 4-hydroxycoumarin (4HC) 
em solventes alternativos obtidos neste trabalho, pode abrir novas perspectivas no 
processamento farmacêutico. As medições do equilíbrio sólido-líquido (SLE) foram feitas 
utilizando um método dinâmico (sintético). O ponto de fusão e a entalpia de fusão dos 
compostos farmacêuticos foram obtidos utilizando differential scanning calorimetry (DSC). A 
solubilidade de N-acetyl-L-cysteine e 4-hydroxycoumarin em líquidos iónicos de 
trifluorometanossulfonato mostrou ser significativamente mais elevada do que nos líquidos 
iónicos de bis(trifluorometilsulfonil)imida estudados, e em comparação, Coumarin tem o 
comportamento oposto. 
O melhor solvente entre os estudados para este antioxidante (NAC) e anticoagulantes (COU e 
4HC) foi encontrado. O equilíbrio de fases sólido-líquido foi descrito utilizando seis equações 
diferentes de correlação que revelaram uma descrição relativamente boa com desvio padrão 
aceitável da gama de temperaturas. 
Além disso, os dados de solubilidade foram usados para calcular os coeficientes de partição 1-
octanol/água e os coeficientes de partição experimentais (logP) observaram-se negativos no 
caso de N-acetyl-L-cysteine e positivos no caso de Coumarin, em cinco temperaturas, sendo 
NAC uma molécula mais hidrofílica e COU mais hidrofóbica. Estes resultados são também 
uma prova da possibilidade de utilização destes compostos como produtos farmacêuticos. 
 
Palavras-chave: Solubilidade, Equilíbrio Sólido-líquido, Líquido Iónico, Propriedades 
Termoquímicas, Coeficiente de Partição, Química Verde. 
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Abstract 
The sufficient solubility of N-acetyl-L-cysteine (NAC), coumarin (COU) and 4-
hydroxycoumarin (4HC) in alternative solvents obtained in this work can open new 
perspectives in pharmaceutical processing. Solid–liquid equilibrium (SLE) measurements 
have been made using a dynamic (synthetic) method. The melting point and the enthalpy of 
fusion of the pharmaceutical compounds were acquired using differential scanning 
calorimetry (DSC). The solubility of N-acetyl-L-cysteine and 4-hydroxycoumarin in 
trifluoromethanesulfonate ionic liquids was found to be significantly higher than in the 
studied bis(trifluoromethylsulfonyl)imide ionic liquids, and when compared, coumarin have 
the opposite behaviour. 
The best solvent amongst studied for this antioxidant (NAC) and anticoagulants (COU and 
4HC) was discovered. The solid–liquid phase equilibrium were described using six different 
correlation equations which revealed relatively good description with the acceptable standard 
deviation temperature range. 
Moreover, the solubility data was used to calculate the 1-octanol/water partition coefficients 
and experimental partition coefficients (logP) was found to be negative in N-acetyl-L-cysteine 
and positive in the case of coumarin, at five temperatures with N-acetyl-L-cysteine being 
more hydrophilic and coumarin more hydrophobic; These results are also proof of the 
possibility of using these compounds as pharmaceutical products. 
 
Keywords: Solubility, Solid–liquid equilibrium, Ionic Liquid, Thermochemical Properties, 
Partition Coefficient, Green Chemistry. 
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1. Introduction 
There is a large variety of pharmaceutical substances used in the manufacture of drugs.
1
 This 
type of manufacture generates high quantities of residues.  Sheldon´s E-factor, defined as the 
mass ratio of waste to desired product, typically reaches E factors of 25-100
2
 for the 
pharmaceutical industry, the highest among the oil refining, and the bulk or fine chemicals 
sectors. For this reason, attention is focused in the development of pharmaceutical processes 
in waste minimization and in assessing its current status in the broad context of green 
chemistry and sustainability. Particularly, the pharmaceutical industry is searching for 
solutions to the problem of waste generation in chemicals manufacture. Hazardous organic 
solvents may be replaced by green solvents, which are advantageous especially in terms of 
volatility and flammability. Ionic liquids have proven their sustainable applications in 
reactions
3,4
 and separations
4,5
 mostly due to their unique tuneable properties, and to their 
thermal stability 
6,7
 and solvent power
[5,8,9,10,11,12,13]
. In general, ILs with a short alkyl chain 
appended in the imidazolium cation and with hydrophilic anions have low toxicity
14,15
. The 
[C4mim] and [C6mim] cations are largely nontoxic towards Caco-2 cells
16
, although a slightly 
higher toxicity was noticed for the surface active cation of [C8mim]. Nevertheless, the toxicity 
of these ionic liquids should not prevent their use as pharmaceutical solvents as many 
pharmaceutical excipients such as the non-ionic surfactants (e.g. polysorbate 80) exhibit 
similar toxicities to many ILs
17
. Moreover, in operations such as granulation, blending, 
compounding and drying, volatile liquids are used, and thus flammable or explosive 
atmospheres can be created. The used flammable solvents has a direct impact on specific 
engineering designs, features of pharmaceutical facilities and process equipment
18
. Due to this 
it is desirable to improve manufacturing processes with solvents recognised as “safer”
18,19
 and 
suitable in pharmaceutical processing
20,21,22
. 
In this work, N-acetyl-L-cysteine (NAC), coumarin and 4-hydroxycoumarin are used 
as examples of interesting pharmaceuticals. NAC may be used in preventing or treating the 
following conditions: acetaminophen poisoning, angina, chronic bronchitis and chronic 
obstructive pulmonary disease, influenza, Acute Respiratory Distress Syndrome, and 
HIV/AIDS
23
.Animal and human studies showed NAC to be a powerful antioxidant and 
potential therapeutic agent in the treatment of cancer and myoclonus epilepsy
24
. Recently, 
NAC was reported to be used in the treatment of Parkinson’s disease
25
. 
Coumarins (coumarin and 4-hydroxycoumarin) have biological activities and are used 
as pharmaceuticals. Their activity includes anti-HIV, anti-tumor, anti-hypertension, anti-
2 
 
arrhythmia, anti-inflammatory, anti-osteoporosis, antiseptic, and analgesic
26
. Coumarin is also 
used in the treatment of asthma
26,
 and lymphedema
27
.
 
Coumarin derivatives are used widely as anticoagulants for the treatment of excessive 
or undesirable blood clotting due to their competitive binding to vitamin K reductase and 
vitamin K epoxide reductase, which are necessary for blood clotting
26
. 4-hydroxycoumarin 
has been used as useful intermediate for the synthesis of anticoagulants, herbicides, and 
anticancer agents
28
. 
 
This work is focused on screening of several ionic liquids as alternative solvents in the 
processing of those substances. Solubility data of coumarin, N-acetyl-L-cysteine and 4-
hydroxycoumarin, in ionic liquids containing the anions bis(trifluoromethylsulfonyl)imide, 
also represented  as Ntf2, and trifluoromethanesulfonate, Otf. The reasons for this choice are 
the current popularity of these anions in the ionic liquid community as replacement for the 
fluorinated PF6 and BF4
29
, and the distinctly different hydrophilicities of the two, with Otf 
much more hydrophilic than Ntf2. We combined these anions with a series of imidazolium-
based cations with growing alkyl chains. It is well known that the length of these alkyl chains 
control the size of the non-polar regions in this type of ionic liquids, leading to different 
solubility behaviours of many solutes.  
To the best of our knowledge, until now there are no studies dedicated to ionic liquids 
and these drugs. In particular, the following ionic liquids were used: 1-ethyl-3-
methylimidazolium bis(trifluoromethylsulfonyl)imide [C2mim][Ntf2], 1-butyl-3-
methylimidazolium bis(trifluoromethylsulfonyl)imide [C4mim][Ntf2], 1-hexyl-3-
methylimidazolium bis(trifluoromethylsulfonyl)imide [C6mim][Ntf2], 1-decyl-3-
methylimidazolium bis(trifluoromethylsulfonyl)imide [C10mim][Ntf2], 1-ethyl-3-
methylimidazolium trifluoromethanesulfonate [C2mim][Otf], 1-butyl-3-methylimidazolium 
trifluoromethanesulfonate [C4mim][Otf]  ionic liquids. Additionally, solubility in water and 1-
octanol were sought to be measured for the following systems: coumarin and N-acetyl-L-
cysteine. 
Such data were needed to calculate 1-octanol/water partition coefficients for the 
investigated systems of the pharmaceutical compounds plus the mentioned solvents. 
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2. Methodology 
2.1. Chemicals 
Coumarin with the stated purity of ≥99 mass% was purchased from Sigma Aldrich as well as 
N-acetyl-L-cysteine with stated purity of ≥99 mass% and 4-hydroxycoumarin with stated 
purity of 98 mass%.  
1-octanol was purchased from Sigma Aldrich with stated purity of ≥99 mass%. Ionic liquids 
[Cnmim][Ntf2] (n = 2, 4, 6, 10) and [C2mim][Otf] were obtained from Solchemar with the 
purity of ≥98 mass% and [C4mim][Otf] were obtained from Iolitec, Germany with the purity 
of ≥99 mass%. 
All ionic liquids were degassed, dried, and freed from residues of volatile compounds by 
applying a vacuum 0.1 Pa at a temperature of 60 ºC. All the drying techniques were carried 
out in the 48 h prior to the preparation of new solutions. The mass fraction of water remaining 
in the dried samples was analysed by coulometric Karl–Fischer titration and showed the 
following amount of water in the pure compounds: [C2mim][Ntf2], 120 ppm; [C4mim][Ntf2], 
110 ppm; [C6mim][Ntf2], 130 ppm; [C10mim][Ntf2], 110 ppm; [C2mim][Otf], 2100 ppm; 
[C4mim][Otf], 3910 ppm.  
 
The chemical structures of drugs and solvents used are illustrated in Table 2.1. 
 
Table 2.1. Name, abbreviation and structure of used solvents and drugs. 
Name, abbreviation Structure 
1-ethyl-3-methylimidazolium 
trifluoromethanesulfonate, 
[C2mim][Otf] 
 
  
1-butyl-3-methylimidazolium 
trifluoromethanesulfonate, 
[C4mim][Otf] 
 
 
4 
 
1-ethyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, 
[C2mim][Ntf2] 
 
1-butyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, 
[C4mim][Ntf2] 
 
 
1-hexyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, 
[C6mim][Ntf2] 
 
1-decyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, 
[C10mim][Ntf2] 
  
 
1-Octanol 
 
 
 
N-acetyl-L-cysteine, NAC 
 
5 
 
Coumarin, COU 
 
4-hydroxycoumarin, 4HC 
 
 
 
2.2. Experimental procedure for SLE measurement 
Solid–liquid equilibria (SLE) of studied systems were obtained at the ambient pressure of 0.1 
MPa and at temperature ranging from 257.58 K to 415.05 K using a dynamic (synthetic) 
method. Experiments were performed in a Pyrex glass cell that was equipped with stirring. 
The cell could be opened/closed by a Teflon valve at the end of a long, capillary-thin (inner 
diameter of 0.1 mm) neck, has shown in Figure 2.1. It allowed the cell to be deeply immersed 
in a temperature-controlled bath, while, at the same time, diminishing losses due to 
evaporation. The solutions were prepared in Pyrex conical 5 mL flasks (Supelco) by weighing 
the pure components with an accuracy of 10
−4
 g. The mixture of solute and solvent was heated 
very slowly (at less than 2 K·h
−1
 near the equilibrium temperature), with continuous stirring 
inside the Pyrex glass cell, placed in a thermostatic bath with ethanol (250–293 K), water 
(293–333 K) or silicon (333–416 K). The last crystal disappearance temperatures, detected 
visually, were measured with a calibrated DOSTMANN electronic P600 thermometer 
equipped in a Pt 100 probe totally immersed in the thermostatic liquid. The uncertainty of the 
temperature measurements was ±0.03 K and that of the mole fraction did not exceed ±0.0005. 
 
Figure 2.1. Picture of cell used in SLE studies. 
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2.3. Differential scanning calorimetry 
The melting temperatures and enthalpies of fusion of the used drugs were obtained by 
differential scanning calorimetry (DSC), according to the following procedure: a sample of up 
to 5 mg was encapsulated in a 40 µL aluminium crucible. The sample was scanned in a 
temperature range from 253 to 573 K. All scans were performed at the heating rate of 5 
K/min. The results are the average of at least three scans. 
The DSC instrument (Mettler Toledo DSC 822e) was calibrated with a sample of indium and 
zinc, both with 99.9999 mol% purity, before each scan. The indium and zinc samples were 
selected because zinc allows for the calibration in the range of temperatures corresponding to 
the expected range for high melting point compounds. 
The calorimetric accuracy was ±1% and the precision was ±0.5%. In respect to melting 
points, the uncertainty was estimated at the level of ±0.5 K. 
 
2.4. 1-Octanol/water partitioning 
One of the most widely used parameters for assessing the environmental impact of a chemical 
specie is the octanol–water partition coefficient (Pow), which is used to model blood/lipid 
partition, and is essential for understanding the tendency of a chemical to cross biological 
membranes.
30
 1-octanol is an amphiphilic solvent with dielectric properties similar to those of 
a generalized lipid phase.
31
 This parameter is useful in the ecosystem risk analysis because 
partition coefficients in octanol–water systems display similarities to the partition of 
biological compounds between water and living organisms. The logarithm of the 
octanol/water partition coefficient (log Po/w) is related to soil organic carbon partition 
coefficients, fish bioconcentration factors, as well as toxicities, for a wide variety of aquatic 
and mammalian species.
32
 Correlations between environmental parameters for natural systems 
and Pow have been successful because of the 1-octanol ability to mimic a lipid phase 
behaviour. 
 
By definition, when equilibrium is reached, the activity of a compound, ai, in both the water-
rich and the octanol-rich phases must be the same (ai
 w
= ai
o
). Since ai = γi xi then:  
 
where xi is the mole fraction and γi is the activity coefficient in the water-rich (
w
) and octanol-
rich (
o
) phases. At constant pressure and temperature, for sufficiently dilute solutions of the 
test compound, mole fractions and concentrations are proportional. Moreover, if the test 
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compound is sufficiently dilute in both phases that it can be considered at “infinite dilution”, 
then the activity coefficients should not change with small variations in the concentrations. In 
this case, namely extremely dilute concentrations (Ci) of the test compound in both phases, 
the partition coefficient should be a constant, independent of composition.
33
 This is also 
called the Nernst distribution law: 
 
 
Generally, hydrophobicity is favourable for bioaccumulation, or the bioconcentration of 
organic compounds.
34 
Therefore, a low value of the 1-octanol/water partition coefficient is 
required for new pharmaceuticals to avoid bioaccumulation. 
 
One must note that octanol and water are not completely immiscible. At 25 ºC, the solubility 
of water in octanol is quite large, 2.46 mol·dm
-3
, 0.289 mole fraction, but the solubility of 
octanol in water is just 3.29x10
-3
 mol·dm
-3
, 9.32x10
-4
 mole fraction.
35
 These solubilities 
depend on the temperature of the solution and can affect the partitioning of the solute between 
the two solvents. 
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3. Results and Discussion 
In this work, different types of results were obtained. In subchapter 3.1, we present the set of 
results that were the main objective of this work, the solubilities of the three above mentioned 
solid  pharmaceutical compounds in the selected ionic liquids, that is, the solid-liquid phase 
diagrams of the systems studied. In subchapter 3.2, a brief discussion of the solubility trends 
uncovered by those results is presented. The auxiliary data obtained by differential scanning 
calorimetry are presented in subchapter 3.3. The solid–liquid phase equilibria were described 
using six different correlation equations as described in subchapter 3.4. Studies of partition 
coefficient of NAC and coumarin was performed, with the purpose to obtain knowledge about 
the absoption efficiency of these compounds, as presented in subchapter 3.5. 
 
3.1. Solid–Liquid Equilibrium (SLE) experimental results  
The aim of this work was to provide solubility data of N-acetyl-L-cysteine, an antioxidant 
drug, coumarin and 4-hydroxycoumarin, anticoagulant derivatives, in alternative solvents 
namely ionic liquids. The (solid + liquid) phase diagrams for N-acetyl-L-cysteine, coumarin 
and 4-hydroxycoumarin in a series of bis(trifluoromethylsulfonyl)imide and 
trifluoromethanesulfonate ionic liquids have been measured by a dynamic method from 
257.58 K to 415.05 K. 
The solubility data of the studied drugs in the aforementioned ionic liquids, water and 1-
octanol, are presented in Tables 3.1.-3.3. The tables compile the direct SLE experimental 
results, temperatures, T1, versus x1 (mole fraction of drug in the saturated solution), for the 
investigated systems. All examined systems are described by the classical solid–liquid phase 
envelopes with the eutectic point below the detection limit. The phase envelopes of the 
systems containing each drug and the studied solvents are shown in Figs. 3.1.–3.3. As shown 
in the figures, the eutectic point is strongly shifted towards low values of the solute mole 
fraction, due to the high melting points and high enthalpies of fusion of the compounds 
studied. 
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Figure 3.1. Solubilities of 4-hydroxycoumarin in [C2mim][Otf] (▲), or [C4mim][Otf] (■), or 
[C4mim][Ntf2] (□).  
 
Table 3.1. Experimental solubilities of 4-hydroxycoumarin (1) in the mentioned ionic liquids 
(2) at temperatures T
a
 and ambient pressure. γ1 is the activity coefficient of 4-
hydroxycoumarin, calculated according to equation (1). 
a
 Standard uncertainties u are u(T) = 0.03 K, ur(x) = 0.0005. 
b
 Reference 36. 
c
 Reference 37. 
d
 
Reference 38. 
240
290
340
390
440
490
0,0 0,1 0,2 0,3 0,4 0,5 0,6 0,7 0,8 0,9 1,0
T
/K
 
mole fraction of solute 
4-hydroxycoumarin 
[C2mim][Otf] [C4mim][Otf] [C4mim][Ntf2] 
x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 
0.0000 262.23
b
  0.0000 290.10
c
  0.0000 270.22
d
  
0.0711 283.02 0.1769 0.0566 293.46 0.3222 0.0203 321.38 2.1513 
0.1107 306.06 0.2490 0.0907 312.45 0.3698 0.0477 340.84 1.5420 
0.1476 323.17 0.3107 0.1197 324.88 0.4019 0.1026 364.94 1.2686 
0.1973 342.78 0.3915 0.1656 340.36 0.4389 0.1615 384.13 1.2060 
0.2485 359.96 0.4684 0.2145 355.49 0.4897 0.2141 399.99 1.2333 
0.3101 372.98 0.4995 0.2728 374.57 0.5872 0.2667 411.60 1.2186 
0.3654 385.07 0.5432 0.3283 387.73 0.6372 1.0000 488.30 1.0000 
0.4204 396.26 0.5860 0.3902 400.96 0.6887    
0.4887 408.56 0.6305 0.4625 415.20 0.7476    
1.0000 488.30 1.0000 1.0000 488.30 1.0000    
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Figure 3.2. Solubilities of N-acetyl-L-cysteine in [C2mim][Otf] (▲), or [C4mim][Otf] (■), or 
[C4mim][Ntf2] (□), or [C6mim][Ntf2] (○), or [C10mim][Ntf2] (◊).  
 
240
260
280
300
320
340
360
380
0,0 0,1 0,2 0,3 0,4 0,5 0,6 0,7 0,8 0,9 1,0
T
/K
 
mole fraction of solute 
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Table 3.2. Experimental solubility of N-acetyl-L-cysteine (1) in the mentioned ionic liquids (2) at Temperatures T
a
 and ambient pressure. γ1 is the 
activity coefficient of the solute
 
, calculated according to equation (1). 
N-acetyl-L-cysteine 
Water [C2mim][Otf] [C4mim][Otf] [C4mim][Ntf2] 
x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 
0.0000 273.15  0.0000 262.23
b
  0.0000 290.10
c
  0.0000 270.22
d
  
0.0110 286.16 3.0696 0.0889 283.34 0.3335 0.0644 293.11 0.7247 0.0866 306.47 0.9574 
0.0142 291.91 3.1108 0.1135 291.49 0.3822 0.1088 311.94 0.9501 0.1769 324.32 0.9371 
0.0173 295.44 2.9961 0.1372 299.83 0.4570 0.1699 324.38 0.9780 0.2692 336.64 0.9517 
0.0212 299.07 2.8578 0.1711 309.26 0.5426 0.2214 332.53 1.0043 0.3559 348.19 1.0534 
0.0287 305.85 2.8105 0.2226 318.74 0.6045 0.2985 340.68 0.9835 0.4642 357.91 1.0913 
0.0405 310.31 2.3888 0.2876 328.22 0.6639 0.3824 349.56 1.0238 0.6006 365.28 1.0485 
0.0498 313.04 2.1697 0.3574 335.74 0.6954 0.4576 355.28 1.0221 0.7422 372.23 1.0336 
0.0627 315.31 1.8817 0.4091 341.94 0.7483 0.5230 359.70 1.0221 0.8775 377.79 1.0185 
0.0856 320.72 1.6952 0.4457 345.81 0.7793 0.6515 368.28 1.0535 1.0000 381.99 1.0000 
0.1128 324.69 1.4901 0.4794 348.83 0.7981 0.8445 376.34 1.0174    
0.1349 328.30 1.4194 0.5341 353.23 0.8222 0.9054 379.13 1.0234    
0.1638 331.91 1.3287 0.5715 355.39 0.8212 1.0000 381.99 1.0000    
0.1871 334.23 1.2607 0.6200 359.34 0.8530       
0.2192 337.75 1.2139 0.6602 361.93 0.8651       
0.2405 340.13 1.1984 0.7026 364.46 0.8753       
0.2607 342.48 1.1954 0.7406 367.93 0.9177       
0.2808 344.30 1.1780 0.7830 370.77 0.9406       
0.3281 348.77 1.1638 0.8398 374.17 0.9640       
0.3779 351.38 1.0971 0.9295 378.61 0.9830       
1.0000 381.99 1.0000 1.0000 381.99 1.0000       
a
 Standard uncertainties u are u(T) = 0.03 K, ur(x) = 0.0005. 
b
 Reference 36. 
c
 Reference 37. 
d
 Reference 38. 
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Table 3.2. (Continuation) 
N-acetyl-L-cysteine 
[C6mim][Ntf2] [C10mim][Ntf2] 1-Octanol 
x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 
0.0000 272.13
e
  0.0000 244.15
f
  0.0000 258.35
g
  
0.0635 298.36 0.9263 0.0102 305.35 7.7493 0.0160 288.30 2.3397 
0.1333 320.58 1.0820 0.0193 323.88 8.4508 0.0321 311.93 3.2233 
0.2424 338.52 1.1266 0.0580 342.61 5.3929 0.0703 330.50 2.9453 
0.3799 352.37 1.1256 0.1360 355.24 3.4340 0.1078 341.24 2.7744 
0.4996 360.96 1.1109 0.2610 365.51 2.4288 0.1756 352.39 2.4368 
0.6236 366.65 1.0507 0.3717 371.43 2.0184 0.2546 360.41 2.1443 
0.7497 372.99 1.0452 0.5157 375.09 1.6102 0.3721 367.69 1.8142 
0.8843 378.10 1.0192 0.6461 376.83 1.3477 0.5052 372.30 1.5217 
1.0000 381.99 1.0000 0.7722 379.26 1.2041 0.6598 376.12 1.2944 
   0.8984 381.04 1.0854 0.8180 379.66 1.1490 
   1.0000 381.99 1.0000 1.0000 381.99 1.0000 
a
 Standard uncertainties u are u(T) = 0.03 K, ur(x) = 0.0005. 
e
 Reference 39,40. 
f
 Reference 41. 
g
 Reference 42. 
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Figure 3.3. Solubilities of Coumarin in [C2mim][Otf] (▲), or [C4mim][Otf] (■),or 
[C2mim][Ntf2] (∆), or [C4mim][Ntf2] (□), or [C6mim][Ntf2] (○), or [C10mim][Ntf2] (◊). 
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Table 3.3. Experimental Solubility of coumarin (1) in the mentioned ionic liquids (2) at Temperatures T
a
 and ambient pressure. γ1 is the activity 
coefficient of the solute
 
, calculated according to equation (1). 
Coumarin 
Water [C2mim][Otf] [C4mim][Otf] [C2mim][Ntf2] 
x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 
0.0000 273.15  0.0000 262.23
b
  0.0000 290.10
c
  0.0000 256.91
d
  
0.00001 294.10  0.0714 275.51 2.6856 0.1463 278.38 1.4310 0.1387 263.58 0.9394 
0.0001 306.28  0.1509 287.63 1.8198 0.2596 292.36 1.2073 0.2512 276.27 0.7813 
0.0003 320.57  0.2400 300.83 1.6378 0.3693 304.12 1.1581 0.3673 288.66 0.7697 
0.0007 326.93 1078.2493 0.3449 310.00 1.4354 0.5206 315.13 1.0761 0.5091 302.03 0.7962 
0.0013 331.80 646.6660 0.4824 318.83 1.2662 0.6415 322.71 1.0404 0.6271 313.49 0.8591 
0.0014 332.76 581.5529 0.6160 326.92 1.1901 0.7743 331.17 1.0382 0.7615 324.60 0.9144 
0.0016 332.85 524.0316 0.7560 333.56 1.1188 0.9060 337.47 1.0131 0.8865 334.28 0.9687 
0.0017 333.95 504.6247 0.8995 338.77 1.0479 1.0000 341.68 1.0000 1.0000 341.68 1.0000 
0.0018 334.38 483.4655 1.0000 341.68 1.0000       
0.0020 334.74 429.2567          
0.0023 335.13 385.1154          
0.0029 336.13 306.7497          
0.0037 336.15 244.6611          
0.0044 336.15 205.2905          
0.0062 336.17 144.5606          
0.0078 336.59 115.3921          
0.0095 336.82 95.7208          
1.0000 341.68 1.0000          
a
 Standard uncertainties u are u(T) = 0.03 K, ur(x) = 0.0005. 
b
 Reference 36. 
c
 Reference 37. 
d
 Reference 43. 
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Table 3.3. (Continuation) 
Coumarin 
[C4mim][Ntf2] [C6mim][Ntf2] [C10mim][Ntf2] 1-Octanol 
x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 x1 T/K γ1 
0.0000 270.22
e
  0.0000 272.13
f
  0.0000 244.15
g
  0.0000 258.35
h
  
0.2879 274.32 0.6415 0.2651 267.71 0.5639 0.4034 276.24 0.4860 0.0107 274.28 17.2411 
0.3920 287.27 0.6933 0.3870 281.91 0.6012 0.4573 284.02 0.5412 0.0272 290.80 11.0473 
0.5068 298.16 0.7230 0.4958 292.67 0.6375 0.5092 289.27 0.5648 0.0593 301.93 6.8194 
0.6332 310.12 0.7843 0.6269 306.70 0.7279 0.5818 298.69 0.6386 0.1043 311.81 4.9599 
0.7637 322.28 0.8655 0.7563 319.94 0.8285 0.6544 307.49 0.7112 0.1704 319.89 3.6731 
0.8844 332.38 0.9327 0.8788 330.92 0.9098 0.7081 313.21 0.7558 0.2338 323.72 2.9202 
1.0000 341.68 1.0000 1.0000 341.68 1.0000 0.7695 320.32 0.8214 0.2904 326.04 2.4754 
      0.8291 326.48 0.8757 0.4014 328.46 1.8890 
      0.8906 332.36 0.9259 0.5376 332.22 1.5293 
      1.0000 341.68 1.0000 0.6805 335.21 1.2867 
         0.8344 338.70 1.1281 
         1.0000 341.68 1.0000 
a
  Standard uncertainties u are u(T) = 0.03 K, ur(x) = 0.0005. 
e
 Reference 38.
f
 Reference 39,40. 
g
 Reference 41. 
h
 Reference 42. 
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3.2. Discussion of SLE results 
The main factor controlling the solubilities in this study is the melting temperature of the 
solutes. This is shown in the following Figures 3.4 to 3.6, where the solubility of the three 
solutes in one ionic liquid at a time is compared. Coumarin, with the lowest melting 
temperature, is more soluble than the others in all examined solvents. Its lower enthalpy of 
fusion also contributes to this behaviour, as it leads to a slower decrease of the solubility with 
decreasing temperature – see equation (1). 
 
Figure 3.4. Comparison between the solubility of coumarin, 4-hydroxycoumarin and N-
acetyl-L-cysteine, in [C4mim][Otf]. Points, experimental results: (♦) coumarin; (▲) N-acetyl-
L-cysteine; (■) 4-hydroxycoumarin. The solid line demonstrates the correlation by the Wilson 
equation. The dashed line illustrates the correlation by the NRTL 1 equation. The dotted line 
represents the correlation by the NRTL equation. 
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Figure 3.5. Comparison between the solubility of coumarin, 4-hydroxycoumarin and N-
acetyl-L-cysteine, in [C4mim][Ntf2]. Points, experimental results: (♦) coumarin; (▲) N-
acetyl-L-cysteine; (■) 4-hydroxycoumarin. Solid line correlation by the UNIQUAC ASM 
equation, dashed line UNIQUAC equation. The dotted line represents the correlation by the 
NRTL 1 equation. 
 
The solvent properties of ionic liquids depend on the interactions of the solute with cation and 
anion. On the other hand, ionic liquids are usually stratified into polar regions, where the 
charged parts of the ions are located and interact with each other via Coulombic forces, and 
non-polar regions. The relative sizes of these different regions determine the hydrophobicity 
or hydrophilicity of the ionic liquids and consequently their characteristics as solvents.  
In Figures 3.1 to 3.3, the behaviour of each of the three solutes studied in this work can be 
compared either in ionic liquids made of cations with alkyl substituents of different length, 
but the same anion, or in ionic liquids with the same cation, but two different anions.  On the 
other hand, the three above mentioned solutes include: (i) two essentially planar, rigid, and 
very similar molecules, coumarin and 4-hydroxycoumarin, with a difference, the OH group, 
that confers higher hydrophilicity to 4-hydroxycoumarin; (ii) a structurally very different 
molecule, more flexible and polar, N-acetyl-L-cysteine. 
When Figures 3.1 and 3.3 are compared, it becomes apparent that 4-hydroxycoumarin and 
coumarin have symmetric behaviours, that is, the factors that induce increase of the solubility 
of one of the substances in a series of ionic liquids lead to a decrease of similar magnitude in 
the solubility of the other one.  
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It may be observed in Figure 3.1 that the solubilities of 4-hydroxycoumarin decrease slightly 
with an increase in the cation alkyl chain for the ionic liquids with the same anion, 
trifluoromethanesulfonate.  The opposite behaviour is shown in Figure 3.3 for coumarin, 
where solubilities are seen to grow slightly, but steadily with alkyl chain length, for the series 
with either the [Otf]
-
 or the [Ntf2]
-
 anions. These effects of the cation series are however much 
smaller than the effect of changing anion, from the more polar [Otf]
-
 to  [Ntf2]
-
. In these cases, 
the solubility of 4-hydroxycoumarin markedly decreases, while it substantially increases for 
coumarin. It is interesting to note how a small structural change, the replacement of a 
hydrogen atom by a hydroxyl group, drastically inverts the solubility trends. On the other 
hand, the results seem to indicate that the interaction with the anions in the ionic liquids 
studied in this work is the dominant factor controlling solubility, although the shift in the 
polar to non-polar balance induced by the increase in length of the alkyl chains cannot be 
neglected. 
As to N-acetyl-L-cysteine, its solubility presents yet another type of behaviour. Figure 3.3 
shows that the solubility is practically insensitive to the swapping of the anions [Otf]
-
 or the 
[Ntf2]
-
 , in the ionic liquids with the cation [C4mim]
+
. On the contrary, it seems to be very 
sensitive to the size of the alkyl chain, markedly decreasing as alkyl chains grow longer. 
Although these trends in solubility are generally consistent with the differences in polarity of 
the solute molecules, their diversity highlights the possibilities brought by the tuneability of 
solvent power in ionic liquids.   
 
3.3 Differential scanning calorimetry results  
Figures 3.6 to 3.8 show the thermographs obtained for 4-hydroxycoumarin, coumarin, and N-
acetyl-L-cysteine. The thermophysical properties derived from these thermographs are given 
in Table 3.4.  
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Figure 3.6. The thermograph of 4-hydroxycoumarin. 
 
 
Figure 3.7. The thermograph of coumarin. 
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Figure 3.8. The thermograph of N-acetyl-L-cysteine. 
 
 
Table 3.4. The thermophysical properties of drugs obtained by the differential scanning 
calorimetry. 
 Parameter Value 
 
 In this work
a
 Literature 
NAC Melting point, Tfus,NAC (K) 381.99 ± 0.26 - 
Enthalpy of fusion, ∆fusHNAC (kJ·mol
−1
) 32.10 ± 0.06 - 
COU Melting point, Tfus,COU (K) 341.68 ± 0.20 342.30 ± 0.04
[44]b
 
Enthalpy of fusion, ∆fusHCOU (kJ·mol
−1
) 19.54 ± 0.06 18.63 ± 0.08
[44]b
 
4HC Melting point, Tfus,4HC (K) 488.30 ± 0.06 483.62 ± 0.42
[45]c
 
 Enthalpy of fusion, ∆fusH4HC (kJ·mol
−1
) 24.49 ± 0.24 23.17 ± 0.17
[45]c
 
a
 Standard uncertainties u are u(Tfus,NAC) = 0.26 K, ur(∆fusHNAC) = 0.06, u(Tfus,COU) = 0.20 K, 
ur(∆fusHCOU) = 0.06, u(Tfus,4HC) = 0.06 K, ur(∆fusH4HC) = 0.24. 
b
 Standard uncertainties u are u(Tfus,COU) = 0.04 K, ur(∆fusHCOU) = 0.08. 
c
 Standard uncertainties u are u(Tfus,4HC) = 0.42 K, ur(∆fusH4HC) = 0.17. 
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3.4. Correlation of (solid + liquid) equilibrium 
The ideal solubility of a solid in a liquid can be calculated admitting that total miscibility 
(x=1) is obtained at the normal melting temperature of the solid, and that the chemical 
potential of the solute in the liquid solution at any lower temperature obeys the expression for 
an ideal solution. For a non-ideal solution, the solute concentration (mole fraction) is replaced 
by the activity a =  x, and the solubility is given by equation (1).  
 
where , , , ,  and  stand for mole fraction, activity coefficient, 
enthalpy of fusion, difference in solute heat capacity between the solid and liquid at the 
melting temperature, melting temperature of the solute (1) and equilibrium temperature, 
respectively. If the solubility x is known, the activity coefficient  can be calculated.  
The second term of the right side of the equation is a usually small corrective term that 
accounts for the change of the enthalpy of fusion with temperature. As data on  are 
not available for the solutes studied in this work, the equation was used in the calculations 
without the second term.  
The equation may be used assuming the simple eutectic mixtures with a full miscibility in the 
liquid and immiscibility in the solid phases. 
In this study, six methods were used to derive the solute activity coefficients  from the so-
called correlation equations that describe the Gibbs excess energy (GE), the Wilson
46
, 
UNIQUAC
47
, UNIQUAC ASM
48
, NRTL
49
, NRTL 1
49
 and NRTL 2
49
. 
The exact mathematical forms of the equations were presented elsewhere
50
. 
The two adjustable parameters of the equations were found by an optimisation technique 
using Marquardt’s or Rosenbrock’s maximum likelihood method of minimisation described 
by the equation: 
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where  is the objective function,  is the number of experimental points,  and 
denotes respectively experimental and calculated equilibrium temperature corresponding 
to the concentration. The ,  and  are model parameters resulting from the minimisation 
procedure. The root-mean-square deviation of temperature was defined as follows:  
 
The pure component parameters r (volume parameter) and q (surface parameter) in the 
UNIQUAC ASM, NRTL, NRTL 1 and NRTL 2 equations were obtained by means of the 
following simple relationships
51
: 
 
 
where  is the molar volume of pure compound i at 298.15 K. The molar volume of solute 
 (298.15 K) was calculated by the group contribution method
52
 and was assumed to be 
156.3 cm
3
·mol
−1
 for coumarin, 112.13 cm
3
·mol
−1
 for 4-hydroxycoumarin and 126.11 
cm
3
·mol
−1
 for N-acetyl-L-cysteine. 
To the best of our knowledge, there are no association data for the studied drugs, thus the 
calculations to the data set of association were carried out by assuming that, at 323.15 K.  
= 21 kJ·mol
-1
, Table 3.5. shows the optimized K, for each system. 
Furthermore, the molar volumes of solvents needed for the correlation were taken from the 
literature in the following order: 187.2, 223.6 cm
3
·mol
−1
 for [C2mim][Otf] and 
[C4mim][Otf]
53
, 257.9, 292.4, 326.2, and 404.0 cm
3
·mol
−1
 for [C2mim][Ntf2], [C4mim][Ntf2], 
[C6mim][Ntf2], [C10mim][Ntf2], respectively
54
.  
The Kretschmer–Wiebe model of association for the developing of two adjustable parameters 
was used
55
. In this work, the value of parameter , a proportionality constant similar to the 
nonrandomness constant of the UNIQUAC ASM, NRTL, NRTL 1 and NRTL 2 equations 
was used in calculations for different binary systems. 
Values of model parameters obtained by fitting to the solubility results are presented in Tables 
3.6.-3.8. together with the corresponding standard deviations. 
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Table 3.5. Optimized association constant K, for each system. 
K (323.15 K),  = 21 kJ·mol
-1
 
 Solute 
Solvent 4-hydroxycoumarin N-acetyl-L-cysteine coumarin 
[C2mim][Otf] 245.44 (NRTL) 
71.84 (NRTL 2) 
4.93 (UNIQUAC ASM) 
4.89 (NRTL) 
4.90 (NRTL 1) 
4.90 (NRTL 2) 
1.65 (UNIQUAC ASM) 
1.66 (NRTL) 
1.66 (NRTL 1) 
1.63 (NRTL 2) 
[C4mim][Otf] 32.03 (NRTL) 
0.87 (NRTL 1) 
4.68 (UNIQUAC ASM) 
5.32 (NRTL) 
5.20 (NRTL 1) 
4.38 (NRTL 2) 
1.76 (UNIQUAC ASM) 
1.83 (NRTL) 
1.92 (NRTL 1) 
1.76 (NRTL 2) 
[C2mim][Ntf2] - - 2.22 (UNIQUAC ASM) 
2.25 (NRTL) 
2.24 (NRTL 1) 
2.23 (NRTL 2) 
[C4mim][Ntf2] 3.73 (UNIQUAC ASM) 
94.83 (NRTL) 
298.00 (NRTL 1) 
39.46 (NRTL 2) 
5.77 (UNIQUAC ASM) 
6.99 (NRTL) 
7.51 (NRTL 1) 
5.39 (NRTL 2) 
2.71 (UNIQUAC ASM) 
2.69 (NRTL) 
2.70 (NRTL 1) 
2.70 (NRTL 2) 
[C6mim][Ntf2] - 6.26 (UNIQUAC ASM) 
8.19 (NRTL) 
7.84 (NRTL 1) 
5.93 (NRTL 2) 
3.00 (UNIQUAC ASM) 
3.06 (NRTL) 
3.04 (NRTL 1) 
3.01 (NRTL 2) 
[C10mim][Ntf2] - 8.96 (UNIQUAC ASM) 
9.18 (NRTL) 
8.82 (NRTL 1) 
8.84 (NRTL 2) 
3.60 (UNIQUAC ASM) 
3.70 (NRTL) 
3.74 (NRTL 1) 
3.64 (NRTL 2) 
1-Octanol - 4.22 (UNIQUAC ASM) 
3.66 (NRTL) 
4.53 (NRTL 1) 
3.75 (NRTL 2) 
1.08 (UNIQUAC ASM) 
1.24 (NRTL) 
1.32 (NRTL 1) 
1.08 (NRTL 2) 
Water - 0.40 (NRTL)  
1.40 (NRTL 1)  
0.28 (NRTL 2)  
361.30 (UNIQUAC ASM) 
871.89 (NRTL) 
0.81 (NRTL 2) 
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Table 3.6. Correlation of the Solubility Data, SLE, of 4-hydroxycoumarin (1) + a solvent (2) by Wilson, UNIQUAC, UNIQUAC ASM, NRTL, 
NRTL 1, and NRTL 2 Equations: Values of Parameters and Deviations 
 Parameters Deviations 
 Wilson UNIQUAC 
UNIQUAC 
ASM 
NRTL NRTL 1 NRTL 2 Wilson UNIQUAC 
UNIQUAC 
ASM 
NRTL NRTL 1 NRTL 2 
 
g12−g22 
g21−g11 
Δu12 
Δu21 
Δu12 
Δu21 
Δg12 
Δg21 
Δg12 
Δg21 
Δg12 
Δg21 
σT
b
 σT
b
 σT
a
 σT
a
 σT
a
 σT
a
 
Solvent J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 K K K K K K 
[C2mim][Otf] -1061.22 -1463.73 223.94 -39252.79 688.37 -3347.36 2.71 2.97 6.08 1.15
b
 6.11
d
 1.06
g
 
 -2796.54 448.87 -1548.27 35784.55 -3897.38 2501.31       
[C4mim][Otf] 48.37 -1636.91 -823.21 -32783.25 -79711.31 -493.80 1.38 1.38 2.45 0.94
b
 1.85
f
 2.33
i
 
 -2903.56 1315.89 42.46 28523.06 -2059.93 -338.22       
[C4mim][Ntf2] 2862.29 -566.64 3988.52 23849.79 74133.03 16074.42 4.96 5.30 2.26 0.78
e
 0.78
c
 1.20
h
 
 -1280.62 1447.86 -2281.42 -8600.94 -13200.76 -2339.52       
a
According to the equation 
 
 
b
Calculated with the third non randomness parameter α =0.01. 
c
Calculated with the third non randomness parameter α =0.05. 
d
Calculated with the third non randomness 
parameter α =0.2. 
e
Calculated with the third non randomness parameter α =0.25. 
f
Calculated with the third non randomness parameter α =0.3. 
g
Calculated with the third non 
randomness parameter α =0.45. 
h
Calculated with the third non randomness parameter α =0.5. 
i
Calculated with the third non randomness parameter α =0.7. 
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Figure 3.9. Solubility of 4-hydroxycoumarin in [C2mim][Otf]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the NTRL 2 equation. 
The dotted line represents the ideal solubility. 
 
Figure 3.10. Solubility of 4-hydroxycoumarin in [C4mim][Otf]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the NRTL equation. 
The dotted line represents the ideal solubility. 
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Figure 3.11. Solubility of 4-hydroxycoumarin in [C4mim][Ntf2]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the NRTL 1 equation. 
The dotted line represents the ideal solubility. 
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Table 3.7. Correlation of the Solubility Data, SLE, of N-acetyl-L-cysteine (1) + a solvent (2) by Wilson, UNIQUAC, UNIQUAC ASM, NRTL, 
NRTL 1, and NRTL 2 Equations: Values of Parameters and Deviations 
 Parameters Deviations 
 Wilson UNIQUAC 
UNIQUAC 
ASM 
NRTL NRTL 1 NRTL 2 Wilson UNIQUAC 
UNIQUAC 
ASM 
NRTL NRTL 1 NRTL 2 
 
g12−g22 
g21−g11 
Δu12 
Δu21 
Δu12 
Δu21 
Δg12 
Δg21 
Δg12 
Δg21 
Δg12 
Δg21 
σT
b
 σT
b
 σT
a
 σT
a
 σT
a
 σT
a
 
Solvent J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 K K K K K K 
[C2mim][Otf] -3529.60 -1635.36 -3081.26 -2493.59 -2949.29 -1971.59 2.47 1.48 0.88 0.83
k
 0.85
k
 1.17
j
 
 12964.09 1438.23 4190.92 1236.19 -696.94 1964.53       
[C4mim][Otf] -1346.74 -1137.41 -2369.01 -3831.80 -18073.63 -39930.85 1.58 2.21 3.90 1.21
h
 1.05
d
 2.65
b
 
 6348.07 1459.61 2873.73 4283.32 18229.19 45810.46       
[C4mim][Ntf2] -458.38 2033.80 -2202.60 -4351.38 -23216.98 -36011.58 1.07 1.01 3.85 0.93
e
 0.83
c
 3.34
b
 
 5063.70 -1289.78 2606.01 1697.98 12897.76 40569.68       
[C6,mim][Ntf2] 116.80 1799.32 -2188.79 -6573.50 -8872.10 -39424.69 1.54 1.33 5.43 0.84
e
 0.34
g
 2.99
b
 
 4715.67 -1038.19 2657.17 7390.78 8299.12 45160.96       
[C10mim][Ntf2] 6516.10 -1285.41 -866.76 24990.77 -7397.75 -5050.86 2.12 3.11 2.44 2.22
b
 2.18
f
 2.25
d
 
 1400.61 3719.55 1664.11 -22103.74 7606.62 6708.47       
1-Octanol 1037.59 2501.96 6218.25 63704.08 28191.88 36375.25 2.53 2.36 5.38 2.60
b
 4.36
c
 2.34
b
 
 7684.78 -684.96 -2369.51 -50293.27 -13684.80 -31734.25       
Water -483.07 4533.14 4029.84 -1004.96 2735.66 4123.80 1.14 1.04 1.31 0.81
i
 0.91
g
 0.91
e
 
 3714.95 1411.15 1542.11 4691.28 1324.25 683.08       
a
According to the equation 
 
b
Calculated with the third non randomness parameter α =0.01. 
c
Calculated with the third non randomness parameter α =0.05. 
d
Calculated with the third non randomness 
parameter α =0.1. 
e
Calculated with the third non randomness parameter α =0.25. 
f
Calculated with the third non randomness parameter α =0.3. 
g
Calculated with the third non 
randomness parameter α =0.35. 
h
Calculated with the third non randomness parameter α =0.6. 
i
Calculated with the third non randomness parameter α =0.8. 
j
Calculated with the 
third non randomness parameter α =0.9. 
k
Calculated with the third non randomness parameter α =1. 
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Figure 3.12. Solubility of N-acetyl-L-cysteine in [C2mim][Otf]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the UNIQUAC ASM 
equation. The dotted line represents the ideal solubility. 
 
Figure 3.13. Solubility of N-acetyl-L-cysteine in [C4mim][Otf]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the NRTL 1 equation. 
The dotted line represents the ideal solubility. 
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Figure 3.14. Solubility of N-acetyl-L-cysteine in [C4mim][Ntf2]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the UNIQUAC 
equation. The dotted line represents the ideal solubility. 
Figure 3.15. Solubility of N-acetyl-L-cysteine in [C6mim][Ntf2]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the NRTL 1 equation. 
The dotted line represents the ideal solubility. 
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Figure 3.16. Solubility of N-acetyl-L-cysteine in [C10mim][Ntf2]. Points represent the 
experimental results. The dashed line demonstrates the correlation by the Wilson equation. 
The dotted line represents the ideal solubility. 
 
Figure 3.17. Solubility of N-acetyl-L-cysteine in water. Points represent the experimental 
results. The dashed line demonstrates the correlation by the NRTL equation. The dotted line 
represents the ideal solubility. 
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Figure 3.18. Solubility of N-acetyl-L-cysteine in 1-Octanol. Points represent the experimental 
results. The dashed line demonstrates the correlation by the NRTL 2 equation. The dotted line 
represents the ideal solubility. 
Figure 3.19. Comparison of solubilities of N-acetyl-L-cysteine in water (▲), or 1-octanol (■). 
Points represent the experimental results. The solid line demonstrates the correlation by the 
NRTL equation. The dashed line demonstrates the correlation by the NRTL 2 equation. 
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Table 3.8. Correlation of the Solubility Data, SLE, of coumarin (1) + a solvent (2) by Wilson, UNIQUAC, UNIQUAC ASM, NRTL, NRTL 1, 
and NRTL 2 Equations: Values of Parameters and Deviations 
 Parameters Deviations 
 Wilson UNIQUAC 
UNIQUAC 
ASM 
NRTL NRTL 1 NRTL 2 Wilson UNIQUAC 
UNIQUAC 
ASM 
NRTL NRTL 1 NRTL 2 
 
g12−g22 
g21−g11 
Δu12 
Δu21 
Δu12 
Δu21 
Δg12 
Δg21 
Δg12 
Δg21 
Δg12 
Δg21 
σT
b
 σT
b
 σT
a
 σT
a
 σT
a
 σT
a
 
Solvent J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 J·mol
−1
 K K K K K K 
[C2mim][Otf] 1958.47 -216.61 3362.09 5692.83 6855.70 1933.67 2.34 2.41 0.95 0.89
i
 0.90
g
 0.93
m
 
 677.20 875.92 -1841.76 -1776.32 -2299.86 -915.02       
[C4mim][Otf] 3126.28 -1156.88 -1331.74 -1611.97 -38470.10 -24409.99 0.73 0.81 2.84 1.68
m
 0.91
b
 2.37
b
 
 -1558.86 1906.39 1532.69 1256.50 30165.90 26883.45       
[C2mim][Ntf2] -870.16 339.23 -1140.19 1571.21 -24232.78 -862.53 3.79 3.87 0.94 0.75
c
 0.84
b
 0.90
l
 
 632.38 -460.54 675.46 -4733.684 13448.83 361.21       
[C4,mim][Ntf2] -1710.34 801.28 -1568.23 -1712.62 -3516.09 -2145.49 1.65 1.91 0.45 0.44
k
 0.45
h
 0.44
h
 
 1355.52 -1005.23 1166.90 -1972.18 -444.60 2268.27       
[C6mim][Ntf2] -1899.38 28.57 -1355.86 833.00 -30063.77 -1117.48 1.84 2.22 0.56 0.43
e
 0.48
b
 0.53
j
 
 1426.80 -1087.89 707.20 -5302.60 12392.19 436.82       
[C10mim][Ntf2] -1366.84 268.03 -2150.18 1985.03 -43290.45 -1307.54 0.46 0.48 0.54 0.41
d
 0.39
b
 0.48
m
 
 -965.61 -739.59 2042.09 -7753.08 15146.32 777.31       
1-Octanol 4854.84 -279.77 493.17 3823.20 4424.74 405.40 2.56 3.91 1.20 0.71
j
 0.67
k
 1.19
b
 
 3002.29 1945.67 531.08 2383.94 2491.81 571.00       
Water   14211.18 168.07  1422.69   4.01 3.23
f
  3.29
k
 
   2862.34 8741.23  5176.03       
a
According to the equation 
 
 
b
Calculated with the third non randomness parameter α =0.01. 
c
Calculated with the third non randomness parameter α =0.05. 
d
Calculated with the third non randomness 
parameter α =0.1. 
e
Calculated with the third non randomness parameter α =0.15. 
f
Calculated with the third non randomness parameter α =0.2. 
g
Calculated with the third non 
randomness parameter α =0.35. 
h
Calculated with the third non randomness parameter α =0.45. 
i
Calculated with the third non randomness parameter α =0.55. 
j
Calculated with 
the third non randomness parameter α =0.7. 
k
Calculated with the third non randomness parameter α =0.75.
 l
Calculated with the third non randomness parameter α =0.8. 
m
Calculated with the third non randomness parameter α =1. 
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Figure 3.20. Solubility of coumarin in [C2mim][Otf]. Points represent the experimental 
results. The dashed line demonstrates the correlation by the NRTL equation. The dotted line 
represents the ideal solubility. 
 
 
Figure 3.21. Solubility of coumarin in [C4mim][Otf]. Points represent the experimental 
results. The dashed line demonstrates the correlation by the Wilson equation. The dotted line 
represents the ideal solubility. 
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Figure 3.22. Solubility of coumarin in [C2mim][Ntf2]. Points represent the experimental 
results. The dashed line demonstrates the correlation by the NRTL equation. The dotted line 
represents the ideal solubility. 
 
 
Figure 3.23. Solubility of coumarin in [C4mim][Ntf2]. Points represent the experimental 
results. The dashed line demonstrates the correlation by the UNIQUAC ASM equation. The 
dotted line represents the ideal solubility. 
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Figure 3.24. Solubility of coumarin in [C6mim][Ntf2]. Points represent the experimental 
results. The dashed line demonstrates the correlation by the NRTL equation. The dotted line 
represents the ideal solubility. 
 
Figure 3.25. Solubility of coumarin in [C10mim][Ntf2]. Points represent the experimental 
results. The dashed line demonstrates the correlation by the UNIQUAC equation. The dotted 
line represents the ideal solubility. 
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Figure 3.26. Solubility of coumarin in water. Points represent the experimental results. The 
dashed line demonstrates the correlation by the NRTL equation. 
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Figure 3.27. Solubility of coumarin in 1-Octanol. Points represent the experimental results. 
The dashed line demonstrates the correlation by the NRTL 1 equation.  
 
 
Figure 3.28. Comparison of solubilities of coumarin in water (▲), or 1-octanol (■). Points 
represent the experimental results. The solid line demonstrates the correlation by the NRTL 
equation. The dashed line demonstrates the correlation by the NRTL 1 equation. 
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4-hydroxycoumarin and N-acetyl-L-cysteine are hydrophilic drugs, with NAC being the most 
hydrophilic one. As expected, positive deviations from ideality ( >1) were found for systems 
with [Ntf2] ionic liquids, where the activity coefficients of solutes are very high (even higher 
than 8). The values of activity coefficients of solutes for [Otf] ionic liquids are significantly 
lower than for [Ntf2] ionic liquids, but in some cases for NAC are still above 1. This can be 
explained by the fact that the interaction between the solute and solvent are stronger resulting 
in a higher solubility of NAC in the studied ionic liquid. 
As predicted, coumarin exhibits the opposite behaviour due to its hydrophobic character. 
Negative deviations from ideality were found for systems with [Ntf2] ionic liquids and the 
activity coefficient of solute,  is lower than 1. 
Considering the correlation of the experimental results, the average standard deviation ( ) 
ranged from 0.34 to 6.11 K. Taking into account the complexity of systems studied here and 
the assumption related to the association constants of the examined drugs, the correlation 
equations gave acceptable . 
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3.5. 1-Octanol/water partition coefficient 
The experimental results for five temperatures are reported in Table 3.9. 
Table 3.9. Solubilities and experimental data for the partition coefficient at 288.15, 298.15, 
308.15, 318.15 and 328.15 K. 
Substance       
   [mol·dm
-3
]
a
 [mol·dm
-3
]
b
   
288.15 K 
NAC 0.0150 0.0124 0.0950 0.6484 0.1465 -0.8342 
COU 0.0146 0.000029 0.0923 0.0016 57.1220 1.7568 
298.15 K 
NAC 0.0183 0.0184 0.1165 0.9327 0.1249 -0.9034 
COU 0.0353 0.000098 0.2234 0.0054 41.4015 1.6170 
308.15 K 
NAC 0.0291 0.0364 0.1847 1.6966 0.1089 -0.9630 
COU 0.0559 0.0002 0.3518 0.0130 27.0679 1.4325 
318.15 K 
NAC 0.0496 0.0729 0.3127 2.9259 0.1069 -0.9712 
COU 0.1076 0.0004 0.6704 0.0233 28.7164 1.4581 
328.15 K 
NAC 0.0829 0.1341 0.5240 4.3804 0.1196 -0.9222 
COU 0.2616 0.0011 1.6260 0.0613 26.5463 1.4240 
a
Calculated with the density of 1-octanol equal to 0.8226 (288.15 K), 0.8226 (298.15 K), 
0.8193 (308.15 K), 0.8085 (318.15 K) and 0.8013 (328.15 K)
56
. 
b
Calculated with the density 
of water equal to 0.9991 (288.15 K), 0.997 (298.15 K), 0.994 (308.15 K), 0.9902 (318.15 K) 
and 0.9857 (328.15 K)
57
. The densities of subcooled solutes at 298.15 K (molar volumes in 
the text) were assumed to be constant at three temperatures. 
 
It is evident that the low aqueous solubility of 1-octanol has a negligible influence on the 
aqueous solubility of drugs. On the other hand, the rather large amount of water present in the 
1-octanol phase (“solute-free”), changes considerably the drugs solubility in the 1-octanol 
phase even if a simple linear dependence of solubility for binary “solute free” solvent was 
assumed. Corresponding values of the drugs solubilities in mutually saturated solvent as a 
molar concentration in water-saturated 1-octanol, are given in Table 3.9. The solute partition 
coefficient of drugs was shown to be less than one in N-acetyl-L-cysteine, and higher than 
one in coumarin.  
40 
 
Figure 3.29. Log P as a function of the temperature for (♦)Coumarin and (▲)N-acetyl-L-
cysteine. The solid lines are calculated by means of polynomials. 
 
While hydrophilic molecules tend to remain in the aqueous phases and hydrophobic 
molecules tend to go into the lipid bilayer, for efficient transport, the drug must be 
hydrophobic enough to partition into the lipid bilayer, but not so hydrophobic, that once it is 
in the bilayer, it will not partition out again (optimal hydrophilic-lipophilic balance).
58
 
Hydrophobic molecules tend to present high octanol/water partition coefficient, while 
hydrophilic molecules have low octanol/water partition coefficient, which can be seen in 
Figure 3.29. 
Coumarin have high partition coefficient, which is considered favourable for the rapid 
absorption of compounds once they are in aqueous solution. This coupled with the fact that 
coumarin is non-polar, suggests that in theory coumarin should cross lipid bilayers easily by 
passive diffusion.
59
 
On the other hand, the solvents used should not have high partition coefficient (in order not to 
be retained in the lipid bilayer). Several studies in bioaccumulation of ionic liquid have been 
performed, and many present high partition coefficient
60,61,62
 but not all
61,63
. This means that 
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special care must be taken to design ionic liquids with increased biodegradabilities and so still 
propose compounds that can be viewed as sustainable. 
 
Table 3.10. Properties of used drugs and solvents. 
 
Melting Point 
Tfus (T/K) 
Enthalpy of fusion 
∆fusH (kJ·mol
−1
) 
Molar Volume 
 (cm
3
·mol
−1
) 
Molar Mass 
MM (g·mol
−1
) 
4-hydroxycoumarin 488.30 24.49 112.13 162.14 
N-acetyl-L-cysteine 381.99 32.10 126.11 163.19 
Coumarin 341.68 19.54 156.30 146.14 
[C2mim][Otf] 262.23 - 187.20 260.23 
[C4mim][Otf] 290.10 - 223.58 288.29 
[C2mim][Ntf2] 256.91 - 257.90 391.31 
[C4mim][Ntf2] 270.22 - 292.40 419.36 
[C6mim][Ntf2] 272.13 - 326.20 447.42 
[C10mim][Ntf2] 244.15 - 404.00 503.53 
1-Octanol 258.35 - 158.31 130.23 
Water 273.15 - 18.07 18.02 
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4. Conclusions 
Data on solubilities of N-acetyl-L-cysteine (antioxidant), coumarin, and 4-hydroxycoumarin 
(anticoagulants) in ionic liquids: four with the   bis(trifluoromethylsulfonyl)imide anion and 
two with trifluoromethanesulfonate, are collected in this work. The provided solubility data 
are in the satisfactory range of solubilities
64
 permitting to conclude that: (1) the studied ionic 
liquids are appropriate solvents for drug manufacturing and (2) such solvents can be suitable 
for pharmaceutical processing.
20,21,64,65
 The binary systems composed of drugs and an ionic 
liquid yield solid–liquid phase equilibrium with the eutectic point shifted towards ionic liquid-
rich solutions. We sought to discover the best solvent amongst the analysed ionic liquids. The 
trifluoromethanesulfonate ionic liquid [C2mim][Otf] was found to be the best solvent for the 
hydrophilic drugs, N-acetyl-L-cysteine and 4-hydroxycoumarin. And in the case of Coumarin, 
the best solvent was [C10mim][Ntf2].  
Analysing solubilities obtained in the case of the bis(trifluoromethylsulfonyl)imide ionic 
liquids, it can be noticed that the solubility of the studied drugs decreases with an increase of 
the alkyl chain in the cation of the ionic liquid for N-acetyl-L-cysteine and 4-
hydroxycoumarin, but have the opposite behaviour in Coumarin. Solid–liquid phase 
equilibrium were described using six different correlation equations (Wilson, UNIQUAC, 
UNIQUAC ASM, NRTL, NRTL 1 and NRTL 2), which allowed for a good description, with 
the standard deviation of temperature in the range of 0.34-6.11K for the examined systems. 
Thermophysical properties of the studied drugs determined by the differential scanning 
calorimetry technique are in good agreement with the literature data. 
The favourable solubilities in alternative solvents obtained within this study for the 
investigated drugs, accompanied by the above mentioned beneficial properties of ionic 
liquids, can allow ionic liquids compete in a “safer” mode than with solvents routinely used in 
pharmaceutical industry. 
Studies of partition coefficient of the present compounds (NAC and coumarin) were 
performed and showed that molecules tend to go into the lipid bilayer, therefore considered 
favourable for the rapid absorption of compounds.  
43 
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